Journal of
Public Health and Epidemiology

  • Abbreviation: J. Public Health Epidemiol.
  • Language: English
  • ISSN: 2141-2316
  • DOI: 10.5897/JPHE
  • Start Year: 2009
  • Published Articles: 644

Full Length Research Paper

Prevalence of hepatitis B virus, its risk factors and co-infection with human immune deficiency virus among clients of voluntary counseling and testing center in Hosanna, Southern Ethiopia

Mekuria Asnakew Asfaw
  • Mekuria Asnakew Asfaw
  • NTD Research and Training Center, Arba Minch University, Ethiopia.
  • Google Scholar
Zeleke Hailemariam Abebo
  • Zeleke Hailemariam Abebo
  • Department of Public Health, College of Medicine and Health Sciences, Arba Minch University, Addis Ababa, Ethiopia.
  • Google Scholar
Alemayehu Bekele Kassahun
  • Alemayehu Bekele Kassahun
  • NTD Research and Training Center, Arba Minch University, Ethiopia.
  • Google Scholar

  •  Received: 10 July 2018
  •  Accepted: 10 August 2018
  •  Published: 31 December 2018


Hepatitis B infection (HBV) infection is a serious public health problem worldwide and its co-infection with human immune deficiency virus (HIV) is common due to shared routes of transmission. An increased mortality due to accelerated hepatic disease progression and the frequent hepatotoxicity caused by antiretroviral therapy are the challenges in the clinical management of HIV. Epidemiological studies on HBV and HBV/HIV co infection are scarce in Ethiopia, particularly at the study area. The aim of this study was to determine the magnitude of HBV, its risk factors and co-infection with HIV among clients of a voluntary counseling and testing (VCT) center in Southern Ethiopia. A facility based cross-sectional study was conducted from 1st February 2016 to 15th March among clients of Nigist Eleni Memorial Hospital VCT Center. Data were collected by face-to-face interview and specific formula sheet as well recorded results of laboratory diagnosis of blood sample from each participant. Both descriptive and inferential statistics were used for data analysis. Multivariable logistic regression modeling was done to identify predictors of HBV. Overall, 331 participants were included in the study. The prevalence of HBV was 8.8%, HBV/HIV co-infection was found in 3.6%. Individuals with a history of multiple sexual partner [AOR = 10.3; 95% CI, 3.71 - 28.83], previous history of invasive procedure [adjusted odds ratio (AOR) = 10.88; 95% CI, 3.84 - 30.86] and history of surgical procedure [AOR = 9.2; 95% CI, 3.1 - 27.88] were identified as in dependent predictors of HBV infection. High HBV infection and HBV/HIV co-infection was found in the study. Previous history of surgical procedure, invasive procedure and multiple sexual partners were identified as independent predictor of HBV infection.

Key words: Hepatitis B virus (HBV), human immune deficiency virus, HBV-HIV co-infection, risk factors, Hosanna.



Hepatitis B infection is caused by the hepatitis B virus (HBV).which is an enveloped DNA virus that infects the liver and causes inflammation and hepatocellular necrosis (WHO,  2015;  Marcellin,  2009).  It  is  one  of  a serious public health problem worldwide (Adibi et al., 2012) and It is 50 to 100 times more contagious than HIV (Verma et al., 2011). Recently,WHO estimates the Global Burden of  Disease  study  as  viral  hepatitis accounts for  approximately 1.34million deaths annually, which is equivalent to the number of deaths from HIV/AIDS (1.3 million), malaria (0.9 million), and tuberculosis (1.3 million) (WHO, 2017; GBD, 2016). Globally, 350 million people are infected with HBV and 33 million people are infected with HIV. Next to Asia, Africa has been highly infected by HIV pandemic and the second for HBV infection. These regions are high endemic areas for HBV (Marcellin, 2009; Burnett et al., 2005). Ethiopia, being part of this region, is ranked as an area with medium to high endemicity for HBV infection, based on previous population surveys (Abebe et al., 2003). As Ethiopia is most hit by HIV infection (prevalence of 2.1%), the likelihood of HBV/HIV co-infection is expected to be high due to shared routes of transmission (FMOH, 2007). WHO set a goal to eliminate viral hepatitis as a public health problem by the year 2030 (WHO, 2016). However, in Ethiopia, there was no mass HBV vaccination to the general population; even the burden of HBV in the community is not adequately addressed. Moreover, information on the magnitude of HBV, its risk factors and prevalence of HBV-HIV co-infection are scarce. Therefore, this study was conducted among clients Nigist Eleni Memorial Hospital voluntary counseling and testing (VCT) center, to determine the prevalence of hepatitis-B surface antigen (HBsAg), its risk factors and prevalence of HIV co-infection. The results of this study will help health authorities and other concerned bodies to design interventions to improve the health status of people infected with HBV and HIV. Further, the study can provide base line information for other studies. So, the study is relevant for policy formulation and health care provision.



Study design, setting and participants

Facility based cross-sectional study was conducted at Nigist Eleni Memorial Hospital VCT center, Hossana, Southern Ethiopia, from 1st February 2016 to 15th  March. The VCT center at the hospital routinely gives HIV counseling and testing for clients. All individuals attending Nigist Eleni Memorial Hospital for VCT testing during the study period were eligible for inclusion in the study. The study area was Hadiya zone, Hossana town, Southern Ethiopia. There is one hospital in the town which serves more than 1.5 million people.

According to 2007 census report and as projected in 2011, total population were 92733 with total number of male 45,875 and female 46,858. The total number of households is 18,925 according to HEWs numbering report.

Sample size was determined using single population proportion


Considering the following assumptions: p = 7.7% (proportion of people infected by HBV) (Belayneh, 2015), Zα/2 is the value of the standard normal distribution corresponding to a significant level of alpha (α) of 0.05, which is 1.96 and desired degree of precision (d) of 3%, the computed sample size was 303 and by adding 10% non-response rate, the total sample size computed was 334. Participants were included in the study using systematic sampling technique. Every other two clients were included by considering the monthly average flow of patient from previous data. For data collection, two counselor nurses and one laboratory technician were recruited; and one supervisor was also recruited. Face-to-face interviews using pretested structured questionnaire were done to collect data on socio-demographic characteristics and other risk factors. Three milliliters of venous blood was collected from each patient. Serum was separated by centrifugation at 3000 rpm for 5 min after the blood has been clotted. Rapid HIV kits (HIV (1 + 2) Antibody Colloidal Gold (KHB, Shanghai Kehua Bio-engineering Co Ltd, China) was used as the screening test, followed by HIV 1/2 STAT-PAK® (Chembio Diagnostics, USA) if positive, where the result of STAT-PAK® is discordant with KHB, a third test, Unigold™ HIV (Trinity Biotech, Ireland, tie breaker)) were used to determine the result. The serum was also tested for HBsAg by one step according to the Guangzhou Wondfo Biotech Co., Ltd (Wondfo) instruction. This test has a sensitivity and specificity of 96.2 and 99.3%, respectively (Belayneh, 2015).

Statistical analysis

First, data were entered into Epi data 3.1 and exported to SPSS version 20 for analysis. Then, data cleaning (editing, recoding, checking for missing values, and outliers) was performed. Missing data were treated using multiple imputations. The basic descriptive summaries of patients’ characteristics and outcome of interest was computed. Bi-variate analysis was used to show the relation between HBV infection and various associated factors.  Finally, all associated variables that results (P < 0.2) with the outcome variable were entered into multivariable logistic regression model using backward likely hood ratio method to identify independent predictor of HBV infection. P-value < 0.05 was considered as statistically significant. Odds ratio (OR) with 95% confidence intervals (CI) were calculated as well.

Data quality control

The tool was adapted from different previous literatures and modified by the study context. It was first prepared in English and translated into Amharic, and then translated back to English by an expert who is fluent in both languages to ensure reliability. Training was given for data collectors and the supervisor on the objectives of the research, how to collect the data through interviewing approach, and data recording. Data collectors already trained for the test kits were used. Pre testing of the questionnaires was made on 16 VCT clients in the nearby district health center a week prior to the actual survey. Consequently, based on the feedback obtained from the pre-test, questions which needed clarification were revised and updated. Daily, the data were strictly revised for completeness, accuracy and clarity by the supervisors and principal investigator. In addition, the data were thoroughly cleaned and carefully entered into computer using Epidata version 3.1 using double entry verification.

Ethical statement

Ethical approval was obtained from Hadiya zone health department. Verbal consent was taken from Nigist Elienie Mohammed Hospital and each participant after the purpose of the study was explained. They were told to withdraw at any time from responding to questions. Participants were informed that all the data obtained from them will be confidential and code was used instead of any personal identifiers. Individuals positive for HBV/HIV were linked to the hospital outpatient department (OPD) for further management.



A total of 331 individuals were in the study, with a response rate of 99.1%. Sixty one percent were females and 64% of the study subjects were in the age range of 28 to 37. The mean (±standard deviation [SD]) age was 33 (5.5) years old. About 74% of the participants were living in urban areas; 76% were married. Sixty one percent of the participants were followers of protestant religion. Nearly 21% of the participants were unemployed. About 60% of participants had a monthly income of ³1000 Ethiopian Birr ($5.45 USD) (Table 1).



As regards the health status characteristics shown in Table 2, 8.15% of participants had a history of surgical procedure, 8.76% of invasive procedures, 6.61% of sexually transmitted infections, 9.97% of multiple sexual partners, 10.57% of using sharing sharp materials, and 4.5% of blood transfusion.



Prevalence of HBV infection and co-infection with HIV

The prevalence of HBsAg was found to be 8.8% (Figure 1). The prevalence of HBV/HIV co-infection was found in 3.6% (Figure 2).




Males were most affected by HBV (10.24%). The prevalence of HBsAg was 14.28% in the age category of 18 to 25 years, 7.14% in age category of 26 to 34 years and 12.9% for those above 34 years old. About 10% of the participants with HBsAg positive results lived in urban areas.  

In bivariate analysis, average  family  income,  previous history of surgery, blood transfusion, alcohol consumption, Khat chewing, cigarette smoking, STI, invasive procedure, and sharing of sharp instruments were selected for inclusion in the multiple logistic regression analysis (P-value <0.2) by backward likelihood method of data entry. Individuals with history of multiple life time sexual partner were about ten times more likely to show HBV surface antigen marker than who did not [AOR = 10.3; 95% CI, 3.71 - 28.83], those with previous history of invasive procedure were about ten times more likely to show HBV surface antigen marker than who did not [AOR = 10.88; 95% CI, 3.84 - 30.86] and individuals with history of  surgical procedure were nine times more likely to be affected by HBV [AOR = 9.2; 95% CI, 3.1 - 27.88] (Table 3). Regression diagnostic procedures were carried out and showed no evidence of multi-co linearity and there was no interaction between the potential predictor variables. Chi-square assumptions were checked and met the criteria.









Overall, the prevalence of HBV among VCT clients of Nigist Elienie Mohammed Hospital VCT center was 8.8% and the magnitude of HIV/HBV co-infection was 3.6%. A study conducted in Addis Ababa (Shimelis, 2008) and Shashemene (Negero et al., 2011) revealed a 5.7% HBsAg prevalence among VCT clients, which is lower than the present study. The difference might be due to difference in socio-economic factors. A prevalence of almost 4% was also reported among pregnant women in Jimma (Awole and Gebre-Selassie, 2005). A community based sero-epidemiological study conducted in Addis Ababa revealed 7% HBsAg prevalence (Abebe, 2003). A hospital based survey at South Gondar showed 6.1% HBsAg prevalence (Balew, 2014). The HBV/HIV co-infection rate in this study is high is consistent with a study done in sub Saharan Africa (Burnett, 2005), Shashemene (Negero et al., 2011) and at Hawassa (Belayneh, 2015). However, a study done at VCT centers in Addis Ababa showed no significant difference between HBsAg carriages per HIV status (Shimelis, 2008). Other study among pregnant HIV infected women in the USA showed a much lower prevalence of HBV as compared to this study (Particia, 2005). The justification of this finding could be due to the fact that in most developed parts of the world the prevalence of HBV infection is low (Burnett, 2005). There was a higher prevalence of HIV/HBV co infection (13.6%) observed in a systematic review conducted in Ghana (Agyeman and Ofori‑Asenso, 2016). The difference could be due to socio-economic difference in the study population.

In  this  study,  a  history  of  invasive  procedures   was significantly associated with HBV infection. This is in agreement with a study conducted in Jimma (Awol and Gebre-Selassie, 2005). A previous history of surgical procedure showed significant association with HBV infection. This result is in line with the results of the studies conducted in Ethiopia at Hawassa (Belayneh, 2015). Individuals with history of multiple life time sexual partners were more likely to show HBsAg positive. This finding was in line with a study conducted inNigeria (Nwokediuko, 2009).

The study has the following limitations. First, since we employed a cross-sectional design, we cannot infer causality. Secondly, the findings of the present study were   based   on     rapid   test   kit   which    might   have underestimated the true prevalence.  In this study, HBV DNA was not detected by polymerase chain reaction  due to  unavailability   of  resources,  as  it  would  allow  early diagnosis  of  HBV  infections  before  surface  antigen  of HBV were detectable in serum. So, prevalence may be underestimated.



A high proportion of HBsAg and HBV/HIV co-infection was found in the study area. A previous history of surgical procedure, invasive procedure and multiple sexual partners was identified as independent predictor of HBV infection. This indicates the importance of strengthening preventive measures including vaccination to risky population and IEC to the general population about transmission of HBV. In addition, routine HBV screening program at VCT centers should be integrated, particularly for clients found positive of HIV antibody. So, HBV carriers could be identified early and managed appropriately.



The authors thank the study participants, supervisors and data collectors for the information provided, without which this work would not have been possible. They also thank Nigist Eleni Hospital for support in duplicating questionnaire.



The authors have not declared any conflict of interests.



Abebe A, Nokes D, Dejene A, et al. (2003). Sero epidemiology of hepatitis B in Addis Ababa, Ethiopia, transmission patterns and vaccine control. Epidemiology Infection 131:757-770.


Adibi P, Akbari L, Kahangi LS, Abdi F (2012). Health-State Utilities in Liver Cirrhosis: A Cross- sectional Study. International Journal of Preventive Medicine 3:94-101.


Agyeman AA, Ofori Asenso R (2016). Prevalence of HIV and hepatitis B co infection in Ghana: a systematic review and meta analysis. AIDS research and therapy 13(1):23.


Awole M, Gebre-Selassie S (2005). Seroprevalence of HBsAg and its risk factors amoung pregnant women in Jimma, Southwest Ethiopia. Ethiopian Journal of Health Development 19(1):45-50.


Balew M, Moges F, Yismaw G, Unakal C (2014). Assessment of Hepatitis B Virus and Hepatitis C Virus Infections and Associated Risk Factors in HIV Infected Patients at Debretabor Hospital, South Gondar, Northwest Ethiopia. Asian Pacific Journal of Tropical Disease: 4:1-7. 


Belayneh F (2015). Prevalence of Hepatitis B Virus Infection and Associated Factors among HIV Positive Adults Attending ART Clinic at Hawassa Referral Hospital, SNNPR, Ethiopia. pen Access Library Journal, 2: e1490.


Burnett R, Francois G, Kew M, Leroux-Loels G, Meheus A, Moosen A, et al (2005). Hepatitis B virus and human immune deficiency virus coinfection in sub Saharan Africa, a call for further investigation. Liver International 25(2):201-224.


Federal Ministry of Health (2007). Guidelines for Management of Opportunistic Infections and Anti Retroviral Treatment in Adolescents and Adults in Ethiopia. 


Global Burden of Disease (GBD) (2016). Causes of Death Collaborators Global, regional and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1151-1210.


Marcellin P (2009). Hepatitis B and hepatitis C in 2009. Liver International 29(1):1-8.


Negero A, Sisay Z, Medhin G (2011). Prevalence of Hepatitis B surface antigen (HBsAg) among visitors of Shashemene General Hospital voluntary counseling and testing center. BMC Research Notes: 4:35.


Nwokediuko S (2009) Risk Factors for Hepatitis B Virus Transmission in Nigerians: A Case-Control Study. The Internet Journal of Gastroenterology 10(1).


Particia S, Scott R, Jeanne S (2005) Prevalence of HBV and HCV infection in pregnant women who are infected with HIV. American Journal of Obstetrics and Gynecology 193(3):1270-1273.


Shimelis T, Torben W, Medhin G, Tebeje M, Andualm A, Demessie F, Mulu A, Tegbaru B, Gebre-Selassie S. Hepatitis B (2008). Hepatitis B virus infection among people attending the voluntary counseling and testing center and anti retroviral therapy clinic of St Paul's General Specilaized Hospital Addis Ababa, Ethiopia. Sexually Transmitted Infections 84(1):37-41.


Verma R, Khanna P, Prinja S, Rajput M, Chawla S, Bairwa M (2011). Hepatitis B Vaccine in national immunization schedule: a preventive step in India. Human vaccines 7(12):1387-1388.


World Health Organization (WHO) (2015). Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. WC- 536.


World Health Organization (WHO) (2017). Global hepatitis report, April, 2017. 



WHO Global health sector strategy on viral hepatitis (2016). Towards ending viral hepatitis. Geneva: World Health Organization